SCHEMBL7958403

SCHEMBL7958403

N=C(N)Nc1ccc2cccc3c2c1-c1ccccc1-3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 4/20 0.42
HSD17B10 Q99714 4/20 0.42
TSHR P16473 3/20 0.42
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
SIGMAR1 Q99720 6/20 0.39
KDM4E B2RXH2 3/20 0.37
GAA P10253 1/20 0.37
CASP1 P29466 3/20 0.36
CASP7 P55210 2/20 0.36
CYP3A4 P08684 1/20 0.36
PABPC1 P11940 1/20 0.36
DNMT1 P26358 1/20 0.36
HPGD P15428 3/20 0.35
HIF1A Q16665 2/20 0.35
TP53 P04637 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4982952 0.87 HSD17B10 (0.45) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL4985451 0.80 SIGMAR1 (0.50) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL6541615 0.78 MAPK1 (0.54) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL5057378 0.76 ALDH1A1 (0.35) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL20391963 0.75 MAPK1 (0.50) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL28989586 0.73 ALDH1A1 (0.60) ALDH1A1HSD17B10TSHRL3MBTL1SIGMAR1
SCHEMBL8887979 0.73 MAPT (0.34) ALDH1A1MAPK1HSD17B10SIGMAR1KDM4E
SCHEMBL27778692 0.72 ALDH1A1 (0.47) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL8331532 0.72 HSD17B10 (0.42) ALDH1A1MAPK1HSD17B10TSHRATM
SCHEMBL7219322 0.71 ALDH1A1 (0.45) ALDH1A1MAPK1HSD17B10TSHRATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174924-B1 Therapeutic guanidines CAMBRIDGE NEUROSCIENCE, INC. 2001-01-16 US disclosed